What are the nicotinic and muscarinic effects of commonly used general anesthetic agents?

Nicotinic and Muscarinic Effects of General Anesthesia

General anesthetics primarily inhibit both nicotinic and muscarinic acetylcholine receptors, with nicotinic receptors being more sensitive to inhibition at clinically relevant concentrations, while muscarinic effects vary significantly by agent and contribute to common side effects including postoperative ileus and cognitive impairment.

Nicotinic Receptor Effects

Inhibition Patterns

General anesthetics potently inhibit neuronal nicotinic acetylcholine receptors (nAChRs) at clinically relevant concentrations 1. The sensitivity hierarchy is important:

• Volatile anesthetics and ketamine are the most potent inhibitors of α4β2 and α3β4 neuronal receptors, with IC50 values in the clinical range 1
• Neuronal nAChRs are more sensitive to anesthetic inhibition than muscle-type receptors, except for the α7 receptor subtype 1
• Isoflurane (0.5 mM) reduces nicotine-induced responses by 86% while having minimal effect on muscarinic responses 2

Clinical Implications

The inhibition of nicotinic transmission likely contributes to:

• Analgesia through modulation of central nicotinic pathways 1
• Hypotension via inhibition of sympathetic ganglionic transmission at α3β4 receptors 1
• Cognitive effects, as nAChRs modulate synaptic transmission in the CNS 3

Agent-Specific Profiles

Different anesthetics show characteristic selectivity ratios (IC50 muscarinic/IC50 nicotinic) 2:

• Ketamine: 38.0 (highly selective for nicotinic)
• Thiopental: intermediate selectivity
• Alphaxalone: lower selectivity
• Diazepam: 3.9 (minimal nicotinic selectivity)

Muscarinic Receptor Effects

Receptor Subtype Sensitivity

Muscarinic m1 receptors are inhibited by anesthetics, but generally at higher concentrations than nicotinic receptors 4:

• Halothane, F3 compound, and ethanol inhibit m1 receptor-mediated currents at pharmacologically relevant concentrations 4
• Intravenous agents (barbiturates, etomidate, propofol) inhibit muscarinic receptors only at concentrations higher than those needed for anesthesia 1

Mechanism of Muscarinic Inhibition

The pathway involves multiple sites 5, 6:

1. G-protein level: Anesthetics inhibit even when receptors are bypassed with GTPγS
2. Muscarinic receptors: Direct receptor inhibition occurs
3. TRPC4/6 channels: Downstream muscarinic cation current (mICAT) is significantly inhibited
   • Isoflurane reduces carbachol-activated mICAT by 63% 5
   • GTPγS-induced current (bypassing receptors) still inhibited by 44% 5

Gastrointestinal Consequences

Postoperative ileus (POI) results from muscarinic pathway disruption 6, 5:

• Acetylcholine normally activates M2/M3 receptors → TRPC4 channels → smooth muscle contraction
• Both isoflurane and ketamine significantly inhibit this pathway even when G-proteins are directly activated 6
• Carbachol-induced intestinal contractions are reduced by ~30% with isoflurane 5
• This explains why prokinetic cholinergic drugs are ineffective for POI - the problem is downstream of receptor activation 6

Arousal and Cognitive Effects

Basal Forebrain Cholinergic System

Cholinergic deficits during anesthesia contribute to desired outcomes but also complications 7:

• Decreased acetylcholine release contributes to amnesia, loss of consciousness, and immobility
• Animals with basal forebrain cholinergic deficits show:
  • Increased behavioral sensitivity to anesthetics
  • Faster induction times
  • Delayed recovery from loss of righting reflex 7

Postoperative Cognitive Dysfunction

Cholinergic deficits may underlie postoperative cognitive impairment, particularly in elderly patients 7:

• Similar mechanism to cholinergic decline in aging and Alzheimer's disease
• Anticholinesterase agents can accelerate emergence from anesthesia with mixed success, depending on the specific anesthetic used 7

Critical Caveats

Muscle Relaxant Context

When considering nicotinic effects in the context of neuromuscular blockade 8:

• Suxamethonium is contraindicated with nAChR upregulation (burns, denervation, critical illness) due to life-threatening hyperkalemia risk
• In myasthenia gravis (nAChR downregulation):
  • Resistance to suxamethonium occurs
  • Increased sensitivity to non-depolarizing agents requires 50-75% dose reduction 8

Agent Selection Considerations

The ratio of muscarinic to nicotinic inhibition varies dramatically between agents 2, suggesting:

• Ketamine's high selectivity for nicotinic receptors may explain its unique anesthetic profile
• Agents with balanced inhibition (like alphaxalone) affect both systems more equally
• This selectivity pattern likely contributes to each agent's characteristic clinical properties

The inhibition of nicotinic responses appears to be a common property of most anesthetics, while differential muscarinic effects distinguish individual agents 2.